Every article, report, and earnings note where PTCT appears.
OHB Pediatrics, which trades as Oak Hill Bio, is going public through a merger with Research Alliance Corp III (Nasdaq: RACC) and expects to close by year-end 2026. The setup offers a Phase 3 rare-disease asset and committed financing, but shareholders should watch redemption risk and heavy dilution closely.
Clinuvel Pharmaceuticals Limited American Depositary Shares are expected to list on NASDAQ on 2026-07-20, but the price range has not been disclosed. The setup looks more like an ADR listing upgrade than a classic new-money IPO, with an established profitable specialty pharma business behind it.
Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.
Generate PTCT ReportCancel anytime